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Objective. In the present study, we aimed to investigate epidemiological, clinical, and etiological characteristics of acute upper
gastro-intestinal bleeding. Materials and Methods. This retrospective study was conducted between January 2003 and December
2008. It concerned all cases of acute upper gastroduodenal bleeding beneﬁted from an urgent gastro-intestinal endoscopy in our
department in Morocco. Characteristics of patients were evaluated in terms of age, gender, medical history, presenting symptoms,
results of rectal and clinical examinations, and endoscopy ﬁndings. Results. 1389 cases were registered. As 66% of the patients were
male, 34% were female. Mean age was 49. 12% of patients had a history of previous hemorrhage, and 26% had a history of NSAID
and aspirin use. Endoscopy was performed in 96%. The gastroduodenal ulcer was the main etiology in 38%, followed by gastritis
and duodenitis in 32.5%. Conclusion. AUGIB is still a frequent pathology, threatening patients’ life. NSAID and aspirin are still the
major risk factors. Their impact due to peptic ulcer remains stable in our country.
1.Introduction
Acute upper gastro-intestinal bleeding (AUGIB) is a very
common medical emergency. It is associated with high
mortality rates despite recent developments in diagnosis
and treatment methods [1, 2]. Peptic ulcer and portal
hypertension are the two main causes [1–3]. In the present
study, we aimed to investigate epidemiological, clinical, and
etiological characteristics of AUGIB and to compare our
results with those of the same endoscopy unit.
2.MaterialsandMethods
This retrospective study was conducted in the Medical
Unit C in Ibn Sina hospital in Morocco, between January
2003 and December 2008. It concerned all cases of AUGIB
having underwent an urgent gastro-intestinal endoscopy in
our department. Firstly, patients’ management was in the
emergency department for setting condition and possible
reanimation and stabilization of their homodynamic status.
The patients were then transferred to our department for
endoscopy. After, they returned to the emergency depart-
ment or their original unit with results. Characteristics of
the patients were evaluated in terms of age, gender, medical
history, presenting symptoms, results of rectal and clinical
examinations, and endoscopy ﬁndings.
3. Results
During this period (2003 to 2008), 1389 who presented
AUGIB were enrolled in this study. As 66% of the patients
weremale,34%werefemalewithasexratioof2.2(Figure 1).
Mean age was 49. The youngest was an adolescent of 12
years old who presented esophageal varices stage III, and
the oldest was a woman of 100 years old who presented
esophagitis stage III.
Three hundred and ﬁfty-eight cases (26%) were enrolled
in 2003 and 121 (9%) in 2004, 237 (17%) in 2005, 322 (23%)
in2006,182(13%)in2007,and169(12%)in2008(Table 1).
While hemorrhage was determined for the ﬁrst time in
1219 (88%) of cases, 170 (12%) had a history of previous
hemorrhage. 362 patients (26%) had used one or more2 ISRN Gastroenterology
Table 1: Distribution of AUGIB by year.
Year Number %
2003 358 26
2004 121 9
2005 237 17
2006 322 23
2007 182 13
2008 169 12
34%
66%
Men
Women
Figure 1: Repartition of patients by gender.
Table 2: Medical history.
Number %
Previous hemorrhage 170 12
Varices 221 16
Gastroduodenal ulcers 181 13
Drugs 362 26
Alcohol 14 1
Cigarettes 136 10
gastrotoxic drugs (aspirin, NSAID, corticosteroids). The
medical history revealed gastric and duodenal ulcers in 13%,
and varices in 16%. Alcohol history was present among 1%
ofpatients,andcigarettesmokingwaspresentamong10%of
them (Table 2).
While 239 (17%) cases described hematemesis, 224
(16%) patients described melena and 897 (65%) described
both hematemesis and melena. 29 patients (2%) had one or
more episodes of important hematochezia requiring the use
of an urgent endoscopy (Figure 2).
Hemorrhagic shock was found in 133 patients (9.5%). 65
patients (4.7%) presented disorders of consciousness. Rectal
examination showed melena in 1028 patients (74%) and
hematochezia in 34 patients (2.5%) (Table 3).
Nine hundred and twenty-four patients of 1015 (93.4%)
had anemia with hemoglobin less than 10g/dL. 157/625
patients (25%) had thrombocytopenia (Table 4).
The most common ﬁnding among endoscopy results was
gastroduodenal ulcer (38%) with 25% for duodenal ulcer
and 13% for gastric ulcer. In 453 cases (32.5%), it was
gastritis and duodenitis. 326 patients (23.5%) had an AUGIB
17%
65%
16%
2%
Melena
Hematochezia Hematemesis and
melena
Hematemesis
Figure 2: Nature of the hemorrhage.
Table 3: Clinical data.
Number %
Hemorrhagic shock 133 9.5
Consciousness disorders 65 4.7
Pallor 1052 76
Melena 1028 74
Hematochezia 34 2.5
Table 4: Biological data.
Number %
Anemia (Hb <10g/dL) 924/1015 91
Hyperleucocytosis 256/614 41
Thrombopenia 157/625 25
Thrombocytosis 37/625 6
by rupture of esophageal varices. In 56 patients (4%), the
endoscopy was strictly normal (Table 5).
4. Discussion
AUGIB is one of the most common emergency conditions
associated with digestive system, and it exhibits signiﬁcant
morbidity and mortality rates [4]. Their early management
is capital because it can reduce mortality, recurrence, and
duration of hospitalization of patients [5, 6]. Upper digestiveISRN Gastroenterology 3
Table 5: Endoscopy ﬁndings in patients.
Number %
Gastroduodenal ulcer 530 38
Gastritis and duodenitis 453 32.5
Esophageal varices 326 23.5
Esophagitis 312 22.5
Cardial varices 108 8
Gastric tumor 50 3.6
Hypertensive gastropathy 41 3
Mallory Weiss 15 1.1
Esophageal tumor 10 0.7
Gastric polyp 8 0.5
Dieulafoy ulcer 4 0.3
Angiodysplasia 4 0.3
Duodenal tumor 3 0.2
Hemobilia 2 0.07
Table 6 :E v o l u t i o no fc a u s e so fA U G I Bi no u rd e p a r t m e n t[ 9].
Year 1982 1991 1999 2006 Our series
Number 460 1062 600 600 1389
Ulcer disease 40% 39% 39% 37% 38%
Esophageal varices 18% 15% 22% 22% 23%
Gastritis and duodenitis 16% 15% 16% 16% 32%
endoscopy is a capital time to precise bleeding source.
If bleeding is not controlled, endoscopy must be done
urgently as soon as security conditions are met. If bleeding is
controlled,itcanbedeferredforseveralhourstoperformthe
act in the best conditions [7]. Currently, there is an overall
decrease in the incidence of AUGIB which remains highly
variable from one study to another [8]. In our series the
incidence has decreased from 26% in 2003 to 12% in 2008.
The incidence of AUGIB has been reported to be 60–
70%, higher among males [8]. In the current study, parallel
with the literature, 66% of our patients were male. Our
population has a mean age of 49 years with extremes
ranging from 12 to 100 years. These data coincide with those
described in the two series in the same endoscopic unit in
1982 and 1999 [9, 10], but they are diﬀerent from those
described in the literature, where the mean age was between
58 and 73 years [5, 8, 11–13]. This can be explained by the
youth of the Moroccan population.
Age is considered by most authors as a capital factor in
the occurrence of AUGIB. They can appear more frequently
in the elderly population [13]. In the present study, 12% of
patients had a history of a previous bleeding. Fiore et al.
reported the rate of patients with a previous bleeding as 19–
23% [15]. Recent studies report a decreasing trend in this
number [16]. Compared to those studies, the rate found in
o u rs t u d yw a so b s e r v e dt ob el o w .
Many studies have shown a relationship between NSAID
and aspirin use, and AUGIB [8, 17]. Gallerani et al.
have conﬁrmed that NSAID compared with other drugs
were associated with the highest risk of hospitalization for
Table 7: Causes of AUGIB (comparison with the literature).
Author Number Ulcer
disease
Gastritis and
duodenitis
Esophageal
varices
Tammaro et al.
(Italy) [5] 436 50% 18% 12%
Kasem et al.
(England) [12] 121 29% 21% 3%
Dursun et al.
(Turkish) [14] 1242 34% 14% 31%
Essaid (Morocco)
[1] 1389 38% 32% 23%
AUGIB [18]. Another study conducted in Spain had shown
an increasing number of deaths by AUGIB in patients treated
with NSAIDs [8]. Corticosteroids do not appear to increase
theriskofulcerbleedingunlesstheyareusedincombination
with NSAIDs [19].
Fiore et al. reported the rate of aspirin use in 1996 and
2000 as 27% and 33%, respectively [15]. Recent studies
demonstrate those rates to be around 40–65% [16]. In the
current study, the rate of NSAID and aspirin use was 26%.
This is higher than the last series of the same endoscopic
unit in 1999 (5%) [9]; this can be explained by the automed-
ication more and more frequent in Moroccan population.
The risk of AUGIB related to the antiplatelet drugs has
been well established. It is especially shown in patients aged
>70 years [20]. The clinician is still facing the problem:
stopping antiplatelet with the risk of thromboembolic com-
plications or continuing with the risk of further bleeding.
The Standards of Practice Committee of the American
Society of Gastro-Intestinal Endoscopy (ASGE) suggests that
patients with AUGIB taking antiplatelet agents should have
these medications withheld until hemostasis is achieved.
Administration of platelets may be appropriate for patients
with life-threatening or serious bleeding. They recommend
that patients with AUGIB receiving anticoagulant therapy
have these agents withheld until hemostasis is achieved [21].
As well as drug use, alcohol and smoking habits have an
important place among risk factors of AUGIB [22]. Fiore et
al. found alcohol habit in 70% of cases having AUGIH [15].
In the present study, the rates of alcohol and smoking were
1% and 10%, respectively.
AUGIB appears in 75% of cases by hematemesis associ-
ated or not with melena, in 20% of cases by melena and in
less than 5% of cases by hematochezia showing evidence of a
veryactivepostpyloricbleeding[4].Thesedatacoincidewith
our series.
The most common underlying cause of AUGIH is peptic
ulcer [15]. Studies show that peptic ulcers are the underlying
reason in 45–60% of patients across the world who present
with AUGIB [15, 16].
Currently, many recent studies tend to show a decreasing
of peptic ulcer disease and its bleeding complications [8].
These studies did not show any decrease in the frequency
of the rupture of esophageal varices [8]. Comparing our
endoscopic data with four previous endoscopic series run
in the same endoscopic unit (Table 6) shows that the ulcer4 ISRN Gastroenterology
disease remains the main etiology of AUGIB despite the
wide spread of inhibitors proton pump, while gastritis
and duodenitis came in second place before the rupture
of esophageal varices, which can be explained by the
increasing use of gastrotoxic drugs. The AUGIB by rupture
of esophageal varices increased comparing to previous series;
this was explained by the increasing incidence of chronic
hepatitis and probably by the better management of portal
hypertension. In diﬀerent series of the literature, peptic ulcer
remains the main cause of AUGIB, followed by the rupture
of esophageal varices [5, 8, 12, 14]( Table 7).
5. Conclusion
Acute upper gastro-intestinal bleeding remains a frequent
pathology, threatening patients’ life. It mainly aﬀects men.
Using gastrotoxic drugs increases the risk of these AUGIB
Peptic ulcer causing AUGIB remains stable in our country.
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